Development of the natural compound silvestrol as antiviral drug candidate for hepatitis E virus and emerging RNA viruses (SILVIR) : Abschlussbericht : [Laufzeit: 1.3.2019-28.02.2023]

Category

Issuing body:

GND

10094896-0

Friedrich-Loeffler-Institut

Date Created:

01.08.2023

Date Issued:

01.08.2023

Date Modified:

01.08.2023

Projekt ID:

FKZ BMBF 16GW0203, Verbundnummer 01186452

DOI:

10.2314/KXP:1888045655

Language:

English

Type of Resource:

Text

Extent:

1 Online-Ressource (25 Seiten, 2,43 MB)

Place Term:

TIBKAT

Publisher:

Friedrich-Loeffler-Institut

Keywords:

Hepatitis-E-Virus; RNS-Viren; Viruzid; SARS-CoV-2; Arzneimittelforschung

DDC subject of DNB:

570 Life science

URL:

https://www.tib.eu/de/suchen/id/TIBKAT:1866392344/Development-of-the-natural-compound-silvestrol

URL:

https://www.tib.eu/de/suchen/id/TIBKAT:1888045655/Development-of-the-natural-compound-silvestrol?cHash=a46f39c5dddad1807f94116bf07147c7

Institution:

Friedrich-Loeffler-Institut, Institute of Novel and Emerging Infectious Diseases